The main contents of today’s Sci tech Innovation Board evening news are: Shanghai Pudong plans to reach 400 billion yuan in the biomedical industry in the next three years; Jidu completed nearly $400 million of round a financing.
[hotspot Focus]
newsletter:
Pudong, Shanghai: it is planned that the scale of biomedical industry will reach 400 billion yuan in the next three years
The action plan for high quality development of biomedical industry in Pudong New Area of Shanghai (2022-2024) was released. In the next three years, the goal of Pudong New Area is to further enhance the discovery ability of new targets and new mechanisms, and the subdivided fields such as small molecule chemical drugs, cell therapy, antibody drugs, minimally invasive intervention and surgery Siasun Robot&Automation Co.Ltd(300024) will reach the international advanced level; The scale of biomedical industry has reached 400 billion yuan, the output value of manufacturing industry has exceeded 100 billion yuan, the revenue of high-tech service industry has exceeded 50 billion yuan, and one 10 billion level enterprise, five 5 billion level enterprises and 15 1 billion level enterprises have been added; Cultivate 2-3 global top 100 enterprises, 8-10 hidden champions in subdivided fields, 20 new listed enterprises, and 10 new large enterprise (external) innovation centers and enterprise R & D institutions above the municipal level; The cluster of industrial service platforms is accelerated, the review and approval and listing supervision are scientific and efficient, the financial services are accurately assisted, the integration of industry and medicine is deeply promoted, the scale of high-end talents continues to maintain China’s leading position, and the development environment of biomedical industry is further optimized.
Tianjin Zhonghuan Semiconductor Co.Ltd(002129) comprehensively raise the price of monocrystalline silicon
Tianjin Zhonghuan Semiconductor Co.Ltd(002129) announced the latest price of silicon wafer. Compared with the previous price, the price has been comprehensively increased to 160 μ M as an example, the price of silicon wafers of different specifications will be increased by 0.4 ~ 0.92 yuan / piece.
Shanghai Junshi Biosciences Co.Ltd(688180) disclose the new progress of two covid-19 oral drugs
According to Shanghai Junshi Biosciences Co.Ltd(688180) WeChat official account, the company’s oral nucleoside anti COVID-19 drug VV116 is currently carrying out global multi center clinical research. 3 I phase studies in China have been completed recently, initially showing that VV116 has good clinical safety. The international multi center II/III phase clinical trial for mild to moderate COVID-19 patients is in progress.
Shanghai Junshi Biosciences Co.Ltd(688180) today also announced that it has reached a cooperation with Suzhou Wangshan wangshui biomedical Co., Ltd. to jointly undertake the research and development of delicious anti covid-19 virus candidate new drug vv993 targeting 3CL protease in countries or regions around the world except Uzbekistan, Kyrgyzstan, Kazakhstan, Turkmenistan and Tajikistan (five Central Asian countries) Production and commercialization.
[announcement of science and innovation board]
Chengdu Xgimi Technology Co.Ltd(688696) : the net profit in 2021 is expected to increase by 80% year-on-year
According to the announcement, the net profit in 2021 is expected to be 484 million yuan, an increase of 80.07% year-on-year. The company’s product market performed well, and the sales volume maintained growth, driving the growth of revenue; The change of the company’s pricing strategy and product structure, as well as the continuous introduction of the company’s self-developed polishing machine, led to the increase of gross profit margin.
Galaxycore Inc(688728) : the net profit in 2021 is expected to increase by 47% – 75% year-on-year
According to the announcement of Galaxycore Inc(688728) , the company expects to realize a net profit attributable to the owners of the parent company of RMB 1.135 billion to RMB 1.35 billion in 2021, with a year-on-year increase of 46.83% to 74.57%. In 2021, the company expects to realize an annual operating revenue of RMB 6.652 billion to RMB 7.492 billion, and the unit price of main products and comprehensive gross profit margin have increased.
Shenzhen Jpt Opto-Electronics Co.Ltd(688025) : the net profit in 2021 is expected to increase by 103% – 137% year-on-year
According to the announcement, the company expects to realize a net profit of 90 million yuan to 105 million yuan in 2021, with a year-on-year increase of 103.17% to 137.03%. Based on this calculation, Q4 net profit is expected to be 29.34 million yuan – 44.34 million yuan, an increase of 66% – 151% month on month.
Crown Advanced Material Co.Ltd(688560) : it is proposed to raise no more than 2 billion yuan
Crown Advanced Material Co.Ltd(688560) announced that it is planned to raise no more than 2 billion yuan for the construction project of aluminum-plastic film with an annual output of 200 million square meters of mingguan lithium film company, the construction project of aluminum-plastic film with an annual output of 100 million square meters of mingguan lithium film company, the construction project of fluorine-free backplane with an annual output of 100 million square meters of Jiaming film company and supplement working capital.
Zhejiang Orient Gene Biotech Co.Ltd(688298) : several overseas medical device registration certificates of covid-19 virus detection reagents and related detection instruments are added
Zhejiang Orient Gene Biotech Co.Ltd(688298) it is announced that the company and its wholly-owned subsidiary HENGJIAN Biotechnology Co., Ltd. of the United States have recently obtained the overseas medical device registration certificates (including EU CE and Columbia medical device registration certificates) of the following covid-19 virus detection reagents and related detection instruments. Such products can be sold in the corresponding certification countries and within the authorization period.
[issuance and approval status]
update of issuance and approval status of 12 companies to be listed on the science and innovation board
municipal Party Committee on the science and Innovation Board: Kyushu first track and chaozhuo aviation branch were approved, and Melander suspended consideration
According to the results of the review meeting of the municipal Party Committee on the science and Innovation Board on January 26, Beijing Jiuzhou first track environmental technology Co., Ltd. and Hubei chaozhuo Aviation Technology Co., Ltd. were approved for the first time, and Nanjing mailande Medical Technology Co., Ltd. suspended the review.
[venture capital wind vane]
Jidu completed nearly US $400 million round a financing and mass production models were launched in 2023
Baidu’s smart car brand Jidu announced that it had completed nearly $400 million of round a financing, which was jointly increased by Baidu and strategic partner Geely. After the financing is completed, Jidu will continue to accelerate the process of R & D and mass production. The first car Siasun Robot&Automation Co.Ltd(300024) concept car will be released at the Beijing auto show in April this year, and the mass production model will be listed in 2023.
“wechain technology” completed a round of financing of tens of millions of yuan
Siasun Robot&Automation Co.Ltd(300024) 3D vision start-up “wechain technology” announced the completion of a round of financing of tens of millions of yuan, which was led by Zhongbo and followed by Hainan Taiyi. This round of financing will be mainly used to strengthen R & D, expand product delivery capacity and expand the market.
“Fourier intelligence” completed 400 million yuan round D financing
Smart Siasun Robot&Automation Co.Ltd(300024) company “Fourier intelligence” completed 400 million yuan of round D financing, which was led by Softbank vision fund phase 2 and followed by Saudi Aramco’s venture capital funds prosperity7 ventures and Yuanjing capital.
“jinzhita technology” completed tens of millions of yuan pre-A round of financing
Private computing enterprise “jinzhita technology” completed tens of millions of yuan of pre-A round of financing, which was led by listed company Wangxin technology, followed by large state-owned Ningbo trading fund, and Xiangqi capital as the exclusive financial adviser.
“Zhipu technology” completed hundreds of millions of yuan of financing
“Smart spectrum technology”, which focuses on spectral vision, announced that it had completed two rounds of financing, a round and a + round, totaling hundreds of millions of yuan. A round was invested exclusively by capital, and a + round was invested by Hillhouse venture capital, which continued to be overweight. The financing will be used for product R & D and market development in the field of spectrum.
“Xingtu exploration” completed tens of millions of yuan of financing
Beijing Xingtu Exploration Technology Co., Ltd. has completed tens of millions of yuan of financing. This round of financing is jointly completed by Weifang Hangdong Aerospace investment and Zibo zhongshuyunzhi investment.
